Join to View Full Profile
1st St SWRochester, MN 55905
Phone+1 507-284-2246
Fax+1 507-284-4455
Dr. Weinshilboum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1971 - 1972- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1967 - 1969
University of Kansas School of MedicineClass of 1967
Certifications & Licensure
MN State Medical License 1972 - 2025
MD State Medical License 1970 - 1991
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1979
Publications & Presentations
PubMed
- The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen.Stephanie L Safgren, Vera J Suman, Roberto A Leon Ferre, Matthew L Kosel, Vered Stearns
Breast Cancer Research and Treatment. 2025-05-01 - Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.Reiner Hoppe, Stefan Winter, Wing-Yee Lo, Kyriaki Michailidou, Manjeet K Bolla
NPJ Breast Cancer. 2025-02-19 - The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention.Mustafa Tuncturk, Shikha Kushwaha, Robin M Heider BS, Tyler Oesterle, Richard Weinshilboum
The International Journal of Neuropsychopharmacology. 2025-02-04
Journal Articles
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionNaveen L Pereira, Verghese Mathew, Charles Cagin, Amir Lerman, Richard Weinshilboum, Charanjit Rihal, JAMA
- DNA Methyltransferase Expression in Triple-Negative Breast Cancer Predicts Sensitivity to DecitabineRichard Weinshilboum, MD, The Journal of Clinical Investigation
Authored Content
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
Press Mentions
10 Pioneering Studies from Mayo Clinic’s Center for Individualized Medicine in 2024December 23rd, 2024- Mayo Clinic’s High-Tech Pursuit of Precision Alcohol Addiction TreatmentAugust 29th, 2024
- Mayo Clinic Study Uses “Mini Brains” to Research Opioid Addiction TreatmentDecember 2nd, 2022
- Join now to see all
Grant Support
- Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed PharmacogenomicsMAYO CLINIC ROCHESTER2024–2029
- Pharmacogenetics Of Phase II Drug Metabolizing EnzymesNational Institute Of General Medical Sciences2010–2011
- PGRN Pharmacogenomic Ontology Network ResourceNational Institute Of General Medical Sciences2010–2011
- Next Generation DNA Sequencing Network ResourceNational Institute Of General Medical Sciences2010–2011
- Pharmacogenomics Of Breast Cancer Adjuvant ChemotherapyNational Human Genome Research Institute2009–2011
- Pharmacogenomics Of Cytosine Arabinoside (Ara-C) And Acute Myelogenous LeukemiaNational Cancer Institute2008–2011
- Training Grant In Clinical PharmacologyNational Institute Of General Medical Sciences2004–2011
- Inherited Variations In Drug Metabolizing EnzymesNational Institute Of General Medical Sciences2004–2010
- Pharmacogenetics Of Phase II Drug Metabolizing EnzymesNational Institute Of General Medical Sciences2004–2009
- Sulfate Conjugation And Drug MetabolismNational Institute Of General Medical Sciences2004–2007
- Staff InvestigatorNational Cancer Institute2004
- Training Grant In Clinical PharmacologyNational Institute Of General Medical Sciences2003
- Pharmacogenetics Of Phase II Drug Metabolizing EnzymesNational Institute Of General Medical Sciences2000–2003
- Sulfate Conjugation And Drug MetabolismNational Institute Of General Medical Sciences1986–2003
- Inherited Variations In Drug Metabolizing EnzymesNational Institute Of General Medical Sciences1985–2003
- Inherited Variations In Drug-Metabolizing EnzymesNational Institute Of General Medical Sciences1994
- Biomedical Research SupportNational Center For Research Resources1985–1990
- General Clinical Research CenterNational Center For Research Resources1986–1988
- General Clincal Research CenterNational Center For Research Resources1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
